HARM REDUCTION COALITION for HARM REDUCTION COALITION
No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Alcohol and Drug Abuse ALC
2012 Consolidated Appropriations Act- fighting the reinstatement of the federal ban on syringe exchange services. Protection of the Prevention and Public Health Fund. Educate members concerned with drug shortages about the lifesaving medication Naloxone which is currently at risk for shortage. Educate the administration about the lifesaving medication naloxone and its need to be included in an overdose prevention strategy.
| Lobbyist | Covered position, as disclosed |
|---|---|
| WHITNEY ENGLANDER | — |
Health Issues HCR
Viral Hepatitis Testing Act of 2011- HR 3381 Viral Hepatitis Testing Act of 2011-S. 1809 Authorize appropriations for testing for viral hepatitis.
| Lobbyist | Covered position, as disclosed |
|---|---|
| WHITNEY ENGLANDER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.